Clinical Trials Directory

Trials / Conditions / Epithelial Ovarian Carcinoma

Epithelial Ovarian Carcinoma

10 registered clinical trials studyying Epithelial Ovarian Carcinoma — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingGenetic Testing Decision Aid
NCT05470920
Massachusetts General HospitalN/A
RecruitingORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
NCT05059444
Guardant Health, Inc.—
RecruitingA Beta-only IL-2 ImmunoTherapY Study
NCT05086692
Medicenna Therapeutics, Inc.Phase 1 / Phase 2
RecruitingA Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care
NCT04834544
Peking University Third HospitalPhase 2
CompletedPharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors
NCT02611024
PharmaMarPhase 1 / Phase 2
CompletedA Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent
NCT02344095
Seoul National University HospitalPhase 1
TerminatedEfficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma
NCT02107378
SOTIO a.s.Phase 2
UnknownStudy of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma
NCT02437812
Gynecologic Oncology AssociatesPhase 2
WithdrawnN-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer
NCT01138137
OHSU Knight Cancer InstitutePhase 1
UnknownIntraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma
NCT00349505
Gustave Roussy, Cancer Campus, Grand ParisPhase 2